Continuous ropivacaine infusion in treatment of postoperative pain in cardiac surgery.

• Conditions: Research is to verify whether continuous infusion of ropivacaine reduces post-operative analgesic requirement after cardiac surgery.; MedDRA version: 12.1Level: LLTClassification code 10019316Term: Heart valve disorders; MedDRA version: 12.1Level: LLTClassification code 10052895Term: Coronary artery insufficiency

• Registration Number: EUCTR2009-017625-20-FI
• Lead Sponsor: Pawel Florkiewicz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2010-05-03
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):